Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: A prospective study in Northern Sweden

International Journal of Cancer

Volumn 107, Issue 1, 2003, Pages 89-93

  Palmqvist, Richard ^a   Stattin, Pär ^a   Rinaldi, Sabina ^b   Biessy, Carine ^b   Stenling, Roger ^a   Riboli, Elio ^b   Hallmans, Göran ^a   Kaaks, Rudolf ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Colon; IGFBP 1, IGFBP 2; Insulin; Rectum

Indexed keywords

INSULIN; INSULIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; SMOKING; SWEDEN;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ODDS RATIO; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042916142     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11362     Document Type: Article

References (22)

1. American Institute for Cancer Research. Food, nutrition and the prevention of cancer: a global perspective. Washington DC: American Institute for Cancer Research, 1996.
2. Giovannucci E. Insulin and colon cancer. Cancer Causes Control 1995;6:164-79.
3. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev 1994;3:687-95.
4. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
5. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 1996;7:605-25.
6. Kaaks R, Lukanova A, Kurzer M. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
7. Weiderpass E, Partanen T, Kaaks R, Vainio H, Porta M, Kauppinen T, Ojajarvi A, Boffetta P, Malats N. Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health 1998;24: 165-74.
8. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A, Savage PJ. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst 1999;91:1147-54.
9. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000;92:1592-600.
10. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, Kaaks R. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 2002;50:642-6.
11. SAS Institute. SAS/STATR user's guide, version 6, 4th ed. Cary, NC: SAS Institute, 1990.
12. Singh P, Rubin N. Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology 1993;105:1218-37.
13. Bjork J, Nilsson J, Hultcrantz R, Johansson C. Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand J Gastroenterol 1993;28:879-84.
14. Watkins LF, Lewis LR, Levine AE. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int J Cancer 1990;45:372-5.
15. Koenuma M, Yamori T, Tsuruo T. Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 1989;80:51-8.
16. Freier S, Weiss O, Eran M, Flyvbjerg A, Dahan R, Nephesh I, Safra T, Shiloni E, Raz I. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 1999;44:704-8.
17. Siddle K, Soos MA, Field CE, Nave BT. Hybrid and atypical insulin/ insulin-like growth factor I receptors. Horm Res 1994;41(Suppl 2): 56-64.
18. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 1996;68:183-223.
19. Vidal-Puig A, Moller DE. Insulin resistance: classification, prevalence, clinical manifestations, and diagnosis. In: Azziz R, Nestler JE, Dewailly D, eds. Androgen excess disorders in women. Philadelphia: Lippincott-Raven, 1997, 227-36.
20. , Ludwig DS. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002;287: 2414-23.
21. Castillo MJ, Scheen AJ, Letiexhe MR, Lefebvre PJ. How to measure insulin clearance. Diabetes Metab Rev 1994;10:119-50.
22. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.